MRSA pneumonia from fatal flu cluster?

Fatal flu clusters

Another family member linked to a fatal flu clusterin Calvert County, Md., has been hospitalized, as suspicion grew that an aggressive drug-resistant form of pneumonia may have

worried MD researching how this happened

played a role in the severe illnesses, according to media reports.

Maryland and Calvert County health officials didn’t report any new details about the cases, but the Washington Post reported yesterday that the sister of the 81-year-old woman who died has been hospitalized at MedStar Washington Hospital Center with fever but no other flu symptoms.

Caring for their mother actually killed two of her daughters

Yesterday the Maryland Department of Health and Mental Hygiene (MDHMH) said seasonal H3N2 influenza had been confirmed in two of the four initial illnesses, which involved the older woman and three of her adult children, two of whom died on Mar 5 after caring for their mother. The second daughter who cared for the woman is recovering at the same Washington, DC, hospital.

Hospital officials have said the patients’ influenza infections were complicated by co-infections with Staphylococcus aureus pneumonia prior to hospitalization, and Calvert County Health Officer David Rogers, MD, told the Post yesterday that the staph infections probably involve methicillin-resistant S aureus (MRSA).

Rogers also told the Post that the mother had been vaccinated against seasonal flu but that the children who cared for her had not.

Tom Skinner, a spokesman for the US Centers for Disease Control and Prevention (CDC), said the CDC was expecting autopsy samples from Maryland to arrive today, and the agency hopes to confirm what pathogens were involved within a few days, according to a USA Today report.

Secondary S aureus pneumonia is a potentially fatal complication of influenza, and one of the hallmarks can be severe necrotizing pneumonia, according to a report on 10 MRSA pneumonia cases, six of them fatal, reported to the CDC from Louisiana and Georgia during a 2-month span in the 2006-07 flu season. The report was published in the Apr 13, 2007, issue of Morbidity and Mortality Weekly Report (MMWR). The patients included both children and adults, and many were previously healthy.

The report details a short interval between respiratory symptom onset and death or isolation of MRSA from the patient. In four of the six fatal cases the patients died within 4 days of symptom onset, which the authors said suggests concomitant flu and MRSA infections, rather than a two-phase pattern seen with other types of flu and pneumonia.

Who would have thought the Flu and MRSA could combine to kill?

Calvert Memorial Hospital, which originally treated some of the patients, said today that it has fielded a number of calls from worried area residents. Paul Pomilla, MD, the hospital’s medical director for infectious diseases, said in the statement, “We understand that many in the community are nervous about the flu after reading media reports about this family’s tragedy, but we want to reassure the public that we are not aware of any other cases of serious influenza-like illness that have a confirmed link to the original patients.”

The hospital advised families to follow routine flu prevention methods and to be vaccinated against flu if they haven’t been already, given the flu season’s late start. Hospital officials said they would continue to monitor flu-like illness patterns seen in the emergency department, urgent care centers, and hospital.

How can you protect yourself?

The single most important issue facing the health care industry today is the occurrence of MRSA in hospitals, surgical wards and in the general community. Deaths from MRSA infections outpace deaths from the AIDS virus in the U.S. and throughout the world. MRSA is responsible for an estimated 94,000 serious infections and over 19,000 deaths a year, according to the October 17, 2007, issue of The Journal of the American Medical Association. 

When antibiotics are administered too often — whether to humans or to animals — a few strong bacteria survive and reproduce, giving rise to new generations of resistant organisms. The use of silver was tested against MRSA and staph in several studies and found to be effective. FDA-certified independent lab tests demonstrate that NutraSilver has zero toxicity to the human body, yet it is utterly lethal to the tested pathogens:
“Colloidal silver has proven to be toxic to all tested species of fungi, bacteria, protozoa, parasites and many viruses. More importantly—unlike conventional antibiotics—infectious agents cannot build a resistance to silver. Taken internally, it may improve digestion; help prevent colds, flu and all organism-caused diseases. It can be used as a douche, atomized, nebulized or inhaled. Applied externally, it has been shown to help with things such as skin abrasions and burns (including sun burn). It can also be dropped into the eyes and ears to help the body overcome infection.”  — Kurt Grange, Ph.D., N.D., nutritional bio-physiologist and author
“My 4 year old daughter has MRSA. As an MD, I had access to virtually every MRSA/Staph treatment available to Western Medicine. Nothing worked.  I applied NutraSilver, a natural mineral, on my daughter topically. She also took small amounts orally. Within 4 days I saw an impressive improvement. NutraSilver really came through for us!”— Mike, MD, 2010
Advertisements

About CareMan
I am the CareMan, have been for 7 years now. I really do care about YOU and getting YOU back to great, natural health, so long as you have an open mind.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: